These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2962555

  • 1. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
    Leander JD.
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 5. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [Abstract] [Full Text] [Related]

  • 6. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS, Robertson HA.
    Brain Res; 1986 Oct 08; 384(2):387-90. PubMed ID: 2946360
    [Abstract] [Full Text] [Related]

  • 8. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1988 Oct 08; 2(4):416-23. PubMed ID: 2973142
    [Abstract] [Full Text] [Related]

  • 9. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 08; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 08; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro.
    Arnt J, Hyttel J.
    J Neural Transm; 1986 Aug 08; 67(3-4):225-40. PubMed ID: 2949056
    [Abstract] [Full Text] [Related]

  • 12. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M, Schinder AF, Gershanik O, Stefano FJ.
    Life Sci; 1989 Aug 08; 44(5):337-46. PubMed ID: 2536881
    [Abstract] [Full Text] [Related]

  • 13. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB, Goldberg LI, Woolverton WL.
    J Pharmacol Exp Ther; 1987 Sep 08; 242(3):804-11. PubMed ID: 2958620
    [Abstract] [Full Text] [Related]

  • 14. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1994 Dec 11; 271(3):1434-43. PubMed ID: 7996456
    [Abstract] [Full Text] [Related]

  • 16. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD, Weiss B.
    J Pharmacol Exp Ther; 1989 May 11; 249(2):507-16. PubMed ID: 2566677
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.
    Arnt J.
    Psychopharmacology Suppl; 1985 May 11; 2():60-1. PubMed ID: 3159011
    [No Abstract] [Full Text] [Related]

  • 18. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1988 May 11; 42(25):2561-7. PubMed ID: 3260320
    [Abstract] [Full Text] [Related]

  • 19. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J, Papp M, Skuza G, Bigajska K, Zazula M.
    J Neural Transm; 1989 May 11; 76(1):29-38. PubMed ID: 2565359
    [Abstract] [Full Text] [Related]

  • 20. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M, Fenu S, Di Chiara G.
    Life Sci; 1987 Jan 19; 40(3):245-51. PubMed ID: 2948094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.